Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: GlaxoSmithKline Research & Development Limited
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients with late stage Parkinson's disease
To characterise the dose response for ropinirole PR as adjunctive treatment to L-dopa in patients with advanced Parkinson's disease.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
A 12-week, randomised, double-blind, placebo-controlled, parallel-group multicentre study to evaluate the anti-inflammatory activity of GW842470 4mg twice daily on pulmonary hyperinflation in patients with chronic obstructive pulmonary disease (COPD)
To evaluate the effects of 12 weeks of administration of GW842470 4mg bid or placebo on pulmonary hyperinflation in terms of residual volume measured by plethysmography in patients with COPD
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 over-expressing Inflammatory Breast Cancer
The primary objective of this study is to compare the progression-free survival between pazopanib in combination with lapatinib versus lapatinib alone in patients with relapsed or refractory IBC whose...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
Study of a new drug combination to treat Chronic Lymphocytic Leukemia
The primary objective of this study is to evaluate the investigator assessed overall response rate (ORR), using the IWCLL updated NCI-WG guidelines [Hallek 2008], in two populations i.e., subjects wit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
A Study to Evaluate the Efficacy and Safety of Two Different Medicines to Treat COPD
The primary objective is to compare the efficacy of UMEC/VI Inhalation Powder (62.5/25 mcg) once-daily with tiotropium (18 mcg) once-daily over 24 weeks for the treatment of subjects with COPD.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
GlaxoSmithKline Research & Development Limited
Update Il y a 5 ans
A Phase III study where the treatment groups are assigned by chance and neither the patient or the study doctor know which treatment the patient will receive that will take place in many sites and will compare the efficacy of Retosiban with placebo in stopping spontaneous preterm labor and prolonging labor
To demonstrate the superiority of retosiban to prolong pregnancy and improve neonatal outcomes compared with placebo
Country
None
organs
None
Specialty
None
unknown
More information
Previous
5
6
7
8
9
10